Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses
Public ClinicalTrials.gov record NCT05025345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Evaluation of the Vision Performance of TECNIS EYHANCE™ Intraocular Lenses With TECNIS SIMPLICITY™ as Compared to TECNIS® 1-piece Intraocular Lenses
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a 6-month, prospective, multicenter, bilateral, randomized subject- and evaluator-masked, clinical investigation of the TECNIS Eyhance IOL versus the TECNIS 1-piece IOL. The study will be conducted at up to 15 sites in the U.S.A and will enroll approximately 220 subjects to achieve approximately 200 randomized and bilaterally implanted subjects, resulting in approximately 100 evaluable subjects in each lens group at 6 months. Subjects are to be implanted with the same IOL in both eyes: TECNIS Eyhance IOL or the TECNIS 1-Piece IOL. The eye implanted first will be considered the primary study eye.
Study identification
- NCT ID
- NCT05025345
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 228 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2021
- Primary completion
- Jun 16, 2022
- Completion
- Jun 16, 2022
- Last update posted
- Aug 27, 2023
2021 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Empire Eye & Laser Center | Bakersfield | California | 93309 | — |
| Southern California Eye Physicians and Associates | Long Beach | California | 90805 | — |
| Center For Sight | Sarasota | Florida | 34239 | — |
| Jones Eye Clinic | Sioux City | Iowa | 51104 | — |
| Chesapeake Eye Care & Laser Center | Annapolis | Maryland | 21401 | — |
| Tekwani Vision Center | St Louis | Missouri | 63128 | — |
| Scott & Christie and Associates, PC | Cranberry Township | Pennsylvania | 16606 | — |
| Eye Care Specialists | Kingston | Pennsylvania | 18704 | — |
| Key-Whitman Eye Center | Dallas | Texas | 75243 | — |
| Berkeley Eye Institute, P.A. | Houston | Texas | 77027 | — |
| Whitsett Vision Group | Houston | Texas | 77055 | — |
| Texas Eye and Laser Center | Hurst | Texas | 76054 | — |
| Focal Point Vision | San Antonio | Texas | 78209 | — |
| Parkhurst NuVision | San Antonio | Texas | 78229 | — |
| R & R Eye Research, LLC | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05025345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2023 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05025345 live on ClinicalTrials.gov.